Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Checkpoint Therapeutics, Inc. - Common Stock (NQ:CKPT)

3.990 UNCHANGED
Streaming Delayed Price Updated: 9:57 AM EDT, Mar 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 489,530
Open 4.000
Bid (Size) 3.990 (804)
Ask (Size) 4.000 (565)
Prev. Close 3.990
Today's Range 3.980 - 4.000
52wk Range 1.380 - 4.500
Shares Outstanding 45,095,500
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
On Friday, there are stocks with unusual volume. Let's take a look.
Let's have a look at what is happening on the US markets on Friday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill
CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc. - CKPT
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
+21.3%
+21.3%
1 Month
+22.8%
+22.8%
3 Month
+17.7%
+17.7%
6 Month
+70.5%
+70.5%
1 Year
+111.1%
+111.1%

More News

Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, CKPT, AMPY on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq - CKPT), Redfin Corporation (Nasdaq - RDFN), Amplify Energy Corp. (NYSE - AMPY), Blackboxstocks Inc. (Nasdaq - BLBX)
From Brodsky & Smith LLC
Via GlobeNewswire
Unusual volume stocks are being observed in Wednesday's session.
Via Chartmill
Unusual volume stocks are being observed in Tuesday's session.
Via Chartmill
Rocket Companies (NYSE: RKT) to Acquire Redfin (NASDAQ: RDFN) in $1.75B Deal – More Stocks to Watch Inside!
Via AB Newswire
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CKPT, RDFN, BLBX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Keep an eye on the top gainers and losers in Monday's session.
Via Chartmill
Monday's session: top gainers and losers
Via Chartmill
Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details
Via Benzinga
Exposures Product Safety
Nasdaq Dips Over 3%; Checkpoint Therapeutics Shares Jump
Via Benzinga
Top movers in Monday's pre-market session
Via Chartmill
CKPT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Checkpoint Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
US Stocks Likely To Open Lower After Trump Hints At Looming Recession: Expert Says Can't Rule Out A Bear Market As Indices Inch Towards Correction Territory
Via Benzinga
Topics Government
Exposures Political
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Shareholder Alert: The Ademi Firm Investigates Whether Checkpoint Therapeutics, Inc. is Obtaining a Fair Price for Its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
This PG&E Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Adoption of Autonomous Drones Rises for Military Operations Fueled by Cutting-Edge Technology
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection
Via Benzinga
Exposures Product Safety
US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'
Via Benzinga
Topics Economy
Exposures Interest Rates

Frequently Asked Questions

Is Checkpoint Therapeutics, Inc. - Common Stock publicly traded?
Yes, Checkpoint Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Checkpoint Therapeutics, Inc. - Common Stock trade on?
Checkpoint Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Checkpoint Therapeutics, Inc. - Common Stock?
The ticker symbol for Checkpoint Therapeutics, Inc. - Common Stock is CKPT on the Nasdaq Stock Market
What is the current price of Checkpoint Therapeutics, Inc. - Common Stock?
The current price of Checkpoint Therapeutics, Inc. - Common Stock is 3.990
When was Checkpoint Therapeutics, Inc. - Common Stock last traded?
The last trade of Checkpoint Therapeutics, Inc. - Common Stock was at 03/18/25 09:57 AM ET
What is the market capitalization of Checkpoint Therapeutics, Inc. - Common Stock?
The market capitalization of Checkpoint Therapeutics, Inc. - Common Stock is 179.93M
How many shares of Checkpoint Therapeutics, Inc. - Common Stock are outstanding?
Checkpoint Therapeutics, Inc. - Common Stock has 180M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.